Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?
Manage episode 153141025 series 1082357
内容由cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD提供。所有播客内容(包括剧集、图形和播客描述)均由 cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
307集单集